Skip to main content
dPCR Market by Product and Geography - Forecast and Analysis 2021-2025

dPCR Market by Product and Geography - Forecast and Analysis 2021-2025

Published: Jul 2021 120 Pages SKU: IRTNTR45377

Market Overview at a Glance

$69.5 B
Market Opportunity
25.17%
CAGR
YoY growth 2020-2021(%)

The dPCR market share is expected to increase by USD 69.5 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 25.17%.

This dPCR market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers dPCR market segmentation by product (consumables and instruments) and geography (North America, Europe, APAC, South America, and MEA). The dPCR market report also offers information on several market vendors, including Avance Biosciences Inc., Becton Dickinson and Co., Bio-Rad Laboratories, Inc, Fluidigm Corp., JN Medsys Pte. Ltd., Merck and Co. Inc., QIAGEN NV, Stilla Technologies Inc., Sysmex Asia Pacific Pte Ltd., and Thermo Fisher Scientific Inc. among others.

What will the dPCR Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the dPCR Market Size for the Forecast Period and Other Important Statistics

 

dPCR Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The demand for high throughput technology is notably driving the dPCR market growth, although factors such as lack of skilled professionals may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the dpcr industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key dPCR Market Driver

The demand for high throughput technology is one of the key factors driving the growth of the global dPCR market. In the last few years, miniaturization of testing systems and automation of technology has increased the throughput by reducing the number of samples required and the duration of time involved in obtaining results. This significantly reduces the wastage of the sample, which can sometimes be expensive based on the type of consumables used. The high throughput technology provides more accurate, specific, and efficient data compared with conventional technology. High throughput dPCR technology provides a high degree of accuracy and productivity in genomic and proteomic research. For instance, Bio-Rad Laboratories' QX200 Droplet Digital PCR (ddPCR) System requires smaller amounts of samples and reagents and provides highly sensitive and precise results. However, the end-users are ready to invest more in high throughput technology to achieve higher efficiency and avoid the repetition of testing that leads to the wastage of samples

Key dPCR Market Trend

The increasing popularity of dPCR will fuel the global dPCR market growth. In the last few years, dPCR technology has been gaining popularity in several applications, including gene testing. The popularity factor can be attributed to its high level of accuracy, precision, sensitivity, and efficiency. For example, end-users such as pharmaceutical and biotechnology companies and research institutes have relied on dPCR solutions to overcome the limitations of traditional PCR technology. Generally, most of the FDA approval for drugs and clinical diagnosis products is dependent on the precision and consistency of results. dPCR helps in achieving the desired precision by increasing the total number of PCR replicates. The advanced dPCR technology helps researchers to complete a drug development process in a short period with a high level of precision and efficiency. Therefore, it has high adoption and acceptability among different end-users.

Key dPCR Market Challenge

The high cost of advanced PCR solutions is a major challenge for the global dPCR market growth. The technological aspects and legality of PCR system approvals involve high expenses, which means PCR-related products, including dPCR solutions, become costly. Most end-users have limited budgets, and sometimes research grants and project funds are very less, which limits the affordability of dPCR instruments and consumables. Such, the high cost of advanced PCR solutions hinders the growth of the market.

This dPCR market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categorizes the global dPCR market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the dPCR market during the forecast period.

Who are the Major dPCR Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Avance Biosciences Inc.
  • Becton Dickinson and Co.
  • Bio-Rad Laboratories, Inc
  • Fluidigm Corp.
  • JN Medsys Pte. Ltd.
  • Merck and Co. Inc.
  • QIAGEN NV
  • Stilla Technologies Inc.
  • Sysmex Asia Pacific Pte Ltd.
  • Thermo Fisher Scientific Inc.

 

This statistical study of the dPCR market encompasses successful business strategies deployed by the key vendors. The dPCR market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Avance Biosciences Inc. - The dPCR provides absolute and precise quantification of nucleic acid without dependence on amplification efficiency.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The dPCR market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

dPCR Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the dPCR market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the global life science tools and services market includes the following core components:

  • Inputs
  • Inbound logistics
  • Operations
  • Outbound logistics
  • Marketing and sales
  • Service
  • Support activities
  • Innovation

The report has further elucidated other innovative approaches being followed by service providers to ensure a sustainable market presence.

Which are the Key Regions for dPCR Market?

For more insights on the market share of various regions Request for a FREE sample now!

45% of the market’s growth will originate from North America during the forecast period. The US is the key market for dPCR market in North America. Market growth in this region will be slower than the growth of the market in regions.

The demand for high throughput technology will facilitate the dPCR market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The dPCR market was positively impacted by the COVID-19 pandemic in 2020. Digital PCR is used in diagnostics and drug discoveries witnessed a significant demand in the market. Industry players have started focusing on developing droplet digital PCR kits to detect COVID-19. Regulatory authorities are also extending support to approve these tests to combat the consequences of the COVID-19 pandemic. However, in 2021, the initiation of large-scale vaccination drives lifted the lockdown and travel restrictions, which led to the resumption of supply chain activities. Such factors are expected to drive the market during the forecast period.

What are the Revenue-generating Product Segments in the dPCR Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The dPCR market share growth in the consumables segment will be significant during the forecast period. The dPCR consumables segment comprises accessories such as generator cartridges, well plates, oil for probes, pipet tips and waste bins, droplet readers, and foil seals that are used in instruments to carry out experiments and tests.

This report provides an accurate prediction of the contribution of all the segments to the growth of the dPCR market size and actionable market insights on post COVID-19 impact on each segment.

dPCR Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 25.17%

Market growth 2021-2025

$ 69.5 billion

Market structure

Concentrated

YoY growth (%)

23.65

Regional analysis

North America, Europe, APAC, South America, and MEA

Performing market contribution

North America at 45%

Key consumer countries

US, China, UK, Germany, and Russian Federation

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Avance Biosciences Inc., Becton Dickinson and Co., Bio-Rad Laboratories, Inc, Fluidigm Corp., JN Medsys Pte. Ltd., Merck and Co. Inc., QIAGEN NV, Stilla Technologies Inc., Sysmex Asia Pacific Pte Ltd., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this dPCR Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive dPCR market growth during the next five years
  • Precise estimation of the dPCR market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the dPCR industry across North America, Europe, APAC, South America, and MEA
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of dPCR market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

dPCR market growth will increase by $ 69.5 bn during 2021-2025.

The dPCR market is expected to grow at a CAGR of 25.17% during 2021-2025.

dPCR market is segmented by Product( consumables, instruments) Geographic( North America, Europe, APAC, South America, MEA)

Avance Biosciences Inc., Becton Dickinson and Co., Bio-Rad Laboratories, Inc, Fluidigm Corp., JN Medsys Pte. Ltd., Merck and Co. Inc., QIAGEN NV, Stilla Technologies Inc., Sysmex Asia Pacific Pte Ltd., Thermo Fisher Scientific Inc. are a few of the key vendors in the dPCR market.

North America will register the highest growth rate of 45% among the other regions. Therefore, the dPCR market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, China, UK, Germany, Russian Federation

  • Demand for high throughput technologyIn the last few years is the driving factor this market.
  • miniaturization of testing systems and automation of technology has increased the throughput by reducing the number of samples required and the duration of time involved in obtaining results. This significantly reduces the wastage of the sample is the driving factor this market.
  • which can sometimes be expensive based on the type of consumables used. The high throughput technology provides more accurate is the driving factor this market.
  • specific is the driving factor this market.
  • and efficient data compared with conventional technology. High throughput dPCR technology provides a high degree of accuracy and productivity in genomic and proteomic research. For instance is the driving factor this market.
  • Bio-Rad Laboratories' QX200 Droplet Digital PCR (ddPCR) System requires smaller amounts of samples and reagents and provides highly sensitive and precise results.Further is the driving factor this market.
  • the rapid technological advances related to PCR have successfully contributed to the development of high throughput dPCR technology capable of yielding results with a high level of accuracy and productivity in genomic and proteomic research. Therefore is the driving factor this market.
  • end-users are ready to invest more in high throughput technology to achieve higher efficiency and avoid the repetition of testing that leads to the wastage of samples. is the driving factor this market.

The dPCR market vendors should focus on grabbing business opportunities from the consumables segment as it accounted for the largest market share in the base year.